(Q54633066)
Statements
Novel 2,3,4,5-tetrahydro-benzo[d]azepine derivatives of 2,4-diaminopyrimidine, selective and orally bioavailable ALK inhibitors with antitumor efficacy in ALCL mouse models. (English)
Eugen F Mesaros
Jason P Burke
Jonathan D Parrish
Benjamin J Dugan
Andrew V Anzalone
Thelma S Angeles
Mark S Albom
Lisa D Aimone
Matthew R Quail
Weihua Wan
Lihui Lu
Zeqi Huang
Mark A Ator
Bruce A Ruggeri
Mangeng Cheng
Gregory R Ott
Bruce D Dorsey
27 October 2010
21
1
463-466